Naura Technology: Order-Driven Revaluation of Advanced Process Platform, Profit Margin Remains the Biggest Variable
Miles Bennett
Multiple investment banks have shifted NAURA's trading thesis from current-quarter profits back to new order growth, arguing that 2026 orders set the 2027 revenue curve — and that margin pressure is the price of admission to this re-rating.
Why is Wall Street counting orders instead of profits?
Goldman Sachs, Citi, J.P. Morgan, UBS, and Bernstein converge on one call: 2026 new-order growth, not current-quarter margins, is the gating variable for a valuation step-up.
This means → the market is pricing a one-year-delay equation: 1Q26 new orders convert to revenue roughly one year later, so 2026 orders effectively shape the 2027 revenue curve.
In plain terms = the banks are no longer asking "how much did you earn this quarter?" but "how thick is your backlog?" — a fat order book earns a growth-stock multiple.
What do the 1Q26 numbers actually say?
1Q26 revenue came in at RMB 10.323 billion, up 26% year-on-year. Gross margin recovered from its 4Q25 trough to roughly 40.8%–41%, but net margin still fell short of some houses' expectations.
Bernstein notes that 1Q26 revenue largely maps to 1Q25 orders — the recognition cycle runs about a year. The tradeable signal is 1Q26 new-order momentum, which is expected to run materially faster than revenue growth.
This reflects a timing mismatch: the income statement tells last year's story, while the stock price needs to discount next year's.
Where are the "advanced-node" orders coming from?
Citi disclosed that management expects China's advanced memory capacity to rise from roughly 80k wafers/month in 2025 to about 120k wafers/month in 2026, with a potentially more aggressive ramp in 2027.
Approximately 60% of 1Q26 new orders came from advanced-logic customers; advanced-memory orders begin surfacing from 2Q26.
This means → NAURA's customer mix is shifting from a single "mature-node import substitution" narrative to a dual engine of "advanced logic + memory expansion" — meaningfully raising the addressable ceiling.
More products, more share — how high can NAURA go?
Morgan Stanley estimates that in 1H25, etch equipment — tools that carve circuit patterns into wafers — accounted for roughly 31% of NAURA's revenue, while deposition equipment — tools that layer thin films onto wafers — contributed about 40%. These two remain the platform's backbone.
J.P. Morgan projects NAURA's share of Chinese WFE demand could rise from about 10% in 2024 to roughly 20% by 2027, driven by advanced fabs' preference for one-stop platform suppliers.
Goldman lists the new-product roadmap: next-gen logic tools, advanced 3D NAND/DRAM tools, HBM hybrid-bonding tools — joining two memory chips face-to-face — and ion implantation. UBS highlights progress on 90:1 high-aspect-ratio etch — etching extremely deep, narrow trenches critical for 300+ layer 3D NAND — noting that a shift from qualification to volume procurement would materially expand NAURA's addressable market.
What does the Kingsemi acquisition add?
J.P. Morgan views NAURA's acquisition of a controlling stake in Kingsemi as a move to fill the track equipment gap — the coater/developer tools that apply and wash photoresist around the lithography step — and strengthen its integrated platform.
Post-consolidation, NAURA can bundle etch, deposition, cleaning, thermal processing, and track tools into a single customer solution.
In plain terms = customers used to shop at several specialist vendors; NAURA now wants to be the "equipment supermarket." But in the near term, Kingsemi's revenue recognition, inventory, and product qualification will make the financials messier — platform-building M&A does not boost net margins overnight.
How bad is the margin pressure, and what would disprove the thesis?
Drags on net margin include: R&D spending, SG&A, employee stock-ownership plan (ESOP) charges, new-product qualification costs, and customer pricing concessions. Goldman is relatively constructive on gross margin; Bernstein worries more about expense ratios — the debate hinges on whether operating leverage materializes as revenue scales.
Goldman forecasts China semiconductor capex at roughly $44.6 billion in 2026 and $44.9 billion in 2027, with domestic AI supply chains a key reason spending stays elevated. Bernstein expects domestic equipment makers' new orders could re-accelerate to above 50% growth.
The falsification checklist over the next four quarters is straightforward: new-order growth, advanced-order mix, gross margin holding above 40%, R&D and SG&A ratios peaking, and year-end ESOP charges being absorbed as expected. If orders stay strong but margins and expense ratios keep deteriorating, the "platform growth stock" narrative collapses back into the old "scale-for-margin" trade-off — the most direct path to disproving the current valuation thesis.
Content is for reference only, not financial advice.